Targeted Medical Pharma to Present at OneMedForum Healthcare Conference

Los Angeles, December 18, 2012 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies , today announced that members of its executive team are scheduled to present at the sixth annual OneMedForum on January 8, 2013 at 3:40 p.m. PST, being held at the Sir Francis Drake Hotel in San Francisco. Management also will conduct one-on-one meetings with investors from January 7-9, 2013, concurrent with the 31st Annual J.P. Morgan Healthcare Conference.

A link to a live webcast of the presentation will be available at the company’s website at http://www.tmedpharma.com/ir-events-and-presentations.  A replay will be available for 90 days following the presentation.

Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a Los Angeles-based specialty pharmaceutical company that develops  prescription medical foods for the treatment of chronic disease including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company manufactures ten proprietary prescription only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical. These prescription medical foods and therapeutic systems are sold to physicians and pharmacies in the U.S. and the Middle East through the company’s subsidiary, Physician’s Therapeutics. These proprietary medications represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. Targeted Medical Pharma also provides diagnostic testing as well as billing and collection services on behalf of dispensing physicians.   

#               #               #

Study Finds Loss of Normal Nighttime Parasympathetic Activity in Veterans Suffering from Gulf War Syndrome

Los Angeles, December 12, 2012 — A scientific paper confirming the relationship between autonomic nervous system dysfunction and Gulf War Illness was published online  November 26, 2012  in the Archives of Neurology, according to Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies.

The paper, “Cholinergic Autonomic Dysfunction in Veterans with Gulf War Illness,” revealed a blunting or loss of normal nighttime parasympathetic activity in veterans suffering from Gulf War Illness was strongly associated with upper gastrointestinal dysmotility and sleep dysfunction.  The abstract of the study can be viewed by visiting: http://bit.ly/CholinergicAutonomicDysfunctionStudy.

“The results of this study confirm our company’s approach to the management of Gulf War Illness and other diseases involving disordered autonomic function,” said William Shell, M.D., CEO and chief scientific officer of Targeted Medical Pharma, Inc., co-author of the scientific paper who provided data, analysis, and manuscript revisions  along with the late Elizabeth Charuvastra, RN, co-founder of Targeted Medical Pharma. “Our company is poised to educate military and civilian healthcare providers how to utilize the prescription-only medical foods Sentra AM® and Sentra PM® as part of a regimen to manage autonomic dysfunction associated with Gulf War Illness and other chronic diseases.”

The scientific paper was primarily designed and implemented by Dr. Robert W. Haley, chief of epidemiology at the University of Texas Southwestern Medical Center, and Dr. Steven Vernino, chief of the neuromuscular division at the University of Texas Southwestern Medical Center.

“This is the first study to establish a medical basis for symptoms of Gulf War Illness in a large, representative sample of veterans using validated medical tests,” said Dr. Haley, principal author of the paper.  “It now gives physicians a medical condition they can test for and treat.”

Funded by the U.S. Department of Veterans Affairs, U.S. Army Medical Research and Material Command, and the National Institute of Health, the study looked at 97 Gulf War-era veterans who met the standardized case definition of Gulf War Illness. The authors of prior studies raised the hypothesis that symptoms in veterans of the 1991Gulf War, such as chronic diarrhea, dizziness, fatigue, and sexual dysfunction, are due to cholinergic autonomic dysfunction.

About Targeted Medical Pharma, Inc.’s Medical Foods

Targeted Medical Pharma’s medical foods are amino acid based, FDA-regulated medications specially formulated to meet the body’s increased nutritional requirements of certain disease states.  They are a safe and effective option for treating pain syndromes, sleep and cognitive disorders, obesity, hypertension and peripheral neuropathy without harmful side effects.  These medical foods are available by prescription only and must be administered under the ongoing supervision of a physician.

The company recently published results from a clinical trial of its proprietary medical food Sentra PM, which demonstrated improved sleep latency and improved nighttime parasympathetic nervous system activity as a standalone medication or used in conjunction with a low dose of Trazadone. The results of the study have been published in the May issue of the Journal of Central Nervous System Disease (http://bit.ly/SentraPM_Study).

Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a specialty pharmaceutical company that develops and sells prescription medical foods to physicians and pharmacies for the treatment of chronic disease including pain syndromes, obesity, peripheral neuropathy, sleep and cognitive disorders.  The company manufactures ten proprietary prescription-only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical.  These prescription medical food products and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs.  Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are currently sold in the United States and the Middle East.  Targeted Medical Pharma also provides cardiac diagnostic testing services as well as billing and collection services on behalf of dispensing physicians.

Forward Looking Statement

This press release may contain forward-looking statements related to the company’s business strategy, outlook, objectives, plans, intentions or goals. The words “may,” “will,” “should,” “plans,” “explores,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Actual results could differ materially. Targted Medical Pharma expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.

 

#               #               #

Targeted Medical Pharma Introduces Medical Food Percura for Dietary Management of Peripheral Neuropathy

Data Shows New Oral Formulation Reduced Symptoms of Pain and Numbness

Los Angeles, December  5, 2012 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies, today reported preliminary data indicating that its new amino acid-based oral formulation PERCURA reduced symptoms of pain and numbness related to peripheral neuropathy in an open-label pilot study.  

“Preliminary study results show medical food PERCURA was able to reduce symptoms found in subjects suffering from peripheral neuropathy related to diabetes,” said William Shell, M.D., CEO and Chief Scientific Officer of Targeted Medical Pharma, Inc. “In 30 percent of the 20 million people suffering from peripheral neuropathy, diabetes is the cause.  Our medical foods treat the nutritional deficiencies found in chronic disease such as diabetes by providing the necessary amino acids to improve clinical outcomes without the negative side effects usually associated with pharmaceutical drugs.”  

The medical food PERCURA reduced symptoms of numbness in subjects an average of 57 percent, after the first 30 days of treatment.  The pilot also reported an average 56 percent reduction in pain among subjects related to peripheral neuropathy after 30 days of treatment.  All subjects are expected to complete the 60-day study by the end of 2012.

About Targeted Medical Pharma, Inc.’s Medical Foods

Targeted Medical Pharma’s medical foods are amino acid based, FDA-regulated medications specially formulated to meet the body’s increased nutritional requirements of certain disease states.  They are a safe and effective option for treating pain syndromes, sleep and cognitive disorders, obesity, hypertension and peripheral neuropathy without harmful side effects.  Physician Therapeutics’ medical foods are available by prescription only and must be administered under the ongoing supervision of a physician.

About  Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc., is a specialty pharmaceutical company that develops and sells prescription medical foods to physicians and pharmacies  for the treatment of certain chronic diseases including  pain syndromes, hypertension, obesity,  sleep and cognitive disorders, and peripheral neuropathy.  Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are sold in the United States and the Middle East. The company manufactures ten proprietary Rx only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical.  These prescription medical foods and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs.

Forward Looking Statement

This press release may contain forward-looking statements related to Targeted Medical Pharma’s business strategy, outlook, objectives, plans, intentions or goals. The words “believe,” “may,” “will,” “should,” “plans,” “explores,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Actual results could differ materially. Targeted Medical Pharma expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.

 

###

 

 

Targeted Medical Pharma to Present at 5th Annual LD Micro Growth Conference

Los Angeles, December 4, 2012 – Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies today announced that members of its executive team are scheduled to present and conduct one-on-one meetings at the LD Micro Growth Conference on December 6, 2012 at 3:30 p.m. Pacific Time. The conference is being held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and sells prescription medical foods to physicians and pharmacies for the treatment of chronic disease including pain syndromes, obesity, sleep and cognitive disorders. The company manufactures nine proprietary prescription only medical foods, as well as 48 convenience packed kits, which pair a medical food and branded or generic pharmaceutical. These prescription medical foods and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs.  Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are currently sold in the United States and the Middle East. Targeted Medical Pharma also provides billing and collection services on behalf of dispensing physicians.